Juvenile Myelomonocytic Leukemia
Oncology
Prevalence
0.5 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| Imetelstat | Assertio Holdings, Inc. (ASRT) |
Frequently asked questions
How many drugs are in development for Juvenile Myelomonocytic Leukemia?
BioSniper tracks 1 drug in development for Juvenile Myelomonocytic Leukemia across 1 company.
How many clinical trials target Juvenile Myelomonocytic Leukemia?
There are 1 clinical trial targeting Juvenile Myelomonocytic Leukemia tracked by BioSniper.
What is the prevalence of Juvenile Myelomonocytic Leukemia?
The estimated prevalence of Juvenile Myelomonocytic Leukemia is approximately 0.5 per 100,000 population.
Deep-dive into Juvenile Myelomonocytic Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis